# Dabigatran Following Transient Ischemic Attack and Minor Stroke

Study · id `cardio:ct-nct02295826` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02295826](<https://clinicaltrials.gov/study/NCT02295826>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02295826

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 300 participants.

## Technical summary

Registry record NCT02295826. Randomized; primary purpose treatment. Start 2015-01 (registry gives no type); primary completion 2018-12-18 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; primary purpose treatment
- Phase: Phase 2
- Enrolled: 300 participants (enrolled count; ClinicalTrials.gov record NCT02295826, source copy `cardio:ctgov-nct02295826-2019-01-30`, retrieved 2026-10-31)
- Start date: 2015-01 (registry gives no type) (ClinicalTrials.gov record NCT02295826, source copy `cardio:ctgov-nct02295826-2019-01-30`, retrieved 2026-10-31)
- Primary completion: 2018-12-18 (actual) (ClinicalTrials.gov record NCT02295826, source copy `cardio:ctgov-nct02295826-2019-01-30`, retrieved 2026-10-31)
- Completion: 2018-12-18 (actual) (ClinicalTrials.gov record NCT02295826, source copy `cardio:ctgov-nct02295826-2019-01-30`, retrieved 2026-10-31)
- Countries: Canada (ClinicalTrials.gov record NCT02295826, source copy `cardio:ctgov-nct02295826-2019-01-30`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02295826-2019-01-30`, retrieved 2026-10-31)

## The registry's words

- Brief title: Dabigatran Following Transient Ischemic Attack and Minor Stroke
- Acronym: DATAS II
- Condition: Transient Ischemic Attack
- Condition: Minor Ischemic Stroke
- Intervention (Drug): Dabigatran
- Intervention (Drug): Acetylsalicylic acid
- Lead sponsor: University of Alberta
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Transient ischemic attack (mini-stroke) (`cardio:transient-ischemic-attack`)
- Registry intervention name matches this record: Dabigatran (`cardio:dabigatran`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry lists this organization as the lead sponsor: University of Alberta (`cardio:org-university-of-alberta`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Dabigatran Treatment of Acute Noncardioembolic Ischemic Stroke (`cardio:pubmed-32098609`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 01d19ee196b19132efa1fd24674c5d08676cf5ab884a110b8cfe3ffc8762a5ea
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
